Literature DB >> 20503283

Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations.

L Clark Paramore1, Parthiv J Mahadevia, Pedro A Piedra.   

Abstract

OBJECTIVE: To identify the frequency of outpatient, non-hospitalized visits for respiratory syncytial virus (RSV) lower respiratory tract infection (LRI) among children and high-risk infants. STUDY
DESIGN: Published studies that reported population-based rates of outpatient RSV illness were reviewed. In addition, we conducted a retrospective cohort study from a national claims database including preterm and full term infants born between April 2004 and April 2006 <6 months of age and continuously enrolled through their first RSV season.
RESULTS: In the selected published studies, rates of outpatient RSV LRI were highest among infants and young children (ranging from 6.9 to 11 per 1,000 children age 1-4 years to 157.5 to 252.0 per 1,000 children age <1 year). In the cohort study, rates of outpatient RSV LRI among preterm infants <or=32 wGA or with chronic lung disease (CLD) ranged from 158.7 to 272.6 visits per 1,000 children. Rates for late preterm (33-36 wGA) infants ranged from 183.3 to 245.7 per 1,000, which was higher than full term infants (128.8 to 171.3 per 1,000).
CONCLUSIONS: Approximately 1 in every 5 of high-risk infants will be affected during their first RSV season, which indicates a fairly high and unrecognized reservoir of disease. Outpatient RSV LRI visits increase with younger age and prematurity.

Entities:  

Mesh:

Year:  2010        PMID: 20503283     DOI: 10.1002/ppul.21224

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

Review 1.  Respiratory syncytial virus vaccine development.

Authors:  Julia L Hurwitz
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

Review 2.  Prematurity and the burden of influenza and respiratory syncytial virus disease.

Authors:  Bernhard Resch; Stefan Kurath-Koller; Monika Eibisberger; Werner Zenz
Journal:  World J Pediatr       Date:  2015-11-19       Impact factor: 2.764

3.  Epidemiology and virology of acute respiratory infections during the first year of life: a birth cohort study in Vietnam.

Authors:  Katherine L Anders; Hoa L Nguyen; Nguyet Minh Nguyen; Nguyen Thi Van Thuy; Nguyen Thi Hong Van; Nguyen Trong Hieu; Nguyen Thi Hong Tham; Phan Thi Thanh Ha; Le Bich Lien; Nguyen Van Vinh Chau; Vu Thi Ty Hang; H Rogier van Doorn; Cameron P Simmons
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

4.  Evaluation of multiple commercial molecular and conventional diagnostic assays for the detection of respiratory viruses in children.

Authors:  F Gharabaghi; A Hawan; S J Drews; S E Richardson
Journal:  Clin Microbiol Infect       Date:  2011-06-24       Impact factor: 8.067

5.  Impact of PCR for respiratory viruses on antibiotic use: theory and practice.

Authors:  Alma C van de Pol; Tom F W Wolfs; Carline E A Tacke; Cuno S P Uiterwaal; Johannes Forster; Anton M van Loon; Jan L L Kimpen; John W A Rossen; Nicolaas J G Jansen
Journal:  Pediatr Pulmonol       Date:  2010-12-30

6.  Molecular epidemiology of human respiratory syncytial virus (HRSV) in Iranian military trainees with acute respiratory symptoms in 2017.

Authors:  Mohammad Hadi Karbalaie Niya; Ali Salimi Jeda; Ahmad Tavakoli; Hesam Sohani; Fahimeh Safarnezhad Tameshkel; Mahshid Panahi; Morteza Izadi; Farhad Zamani; Hossein Keyvani
Journal:  Iran J Microbiol       Date:  2020-10

7.  Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants.

Authors:  Joseph B Domachowske; Anis A Khan; Mark T Esser; Kathryn Jensen; Therese Takas; Tonya Villafana; Filip Dubovsky; M Pamela Griffin
Journal:  Pediatr Infect Dis J       Date:  2018-09       Impact factor: 2.129

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.